BRANDEE BOCAGE: Open Payments
NPI 1124565510 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,353 in 46 payments from 14 companies in 2025. Trend: 2023 $1,093 · 2024 $1,037 · 2025 $1,353
Food & beverage: $1,353
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 8 | $357 |
| ABBVIE INC. | 11 | $260 |
| Novo Nordisk Inc | 5 | $190 |
| GENZYME CORPORATION | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 6 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Lundbeck LLC | 2 | $42 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
Products named: Korlym, VRAYLAR, Wegovy, FABRAZYME, BREZTRI, UBRELVY, Kerendia, REXULTI.
Industry payments across LA — which companies pay providers there.
